Szukaj

108 Result(s)
Sortuj według

Choroby psychiczne

Choroby psychiczne

Boehringer Ingelheim stawia na badania naukowe i rewolucjonizuje dziedzinę zdrowia psychicznego, opracowując nowe terapie i leki. Dowiedz się więcej.
Submit Your Opportunity

Submit Your Opportunity

Information on how to submit a partnering opportunity direct to Boehringer Ingelheim’s Business Development & Licensing team
Bovela®

Bovela®

Reduces hyperthermia and minimises the reduction of leukocyte count caused by BVD virus (BVDV-1, BVDV-2); reduces virus shedding and viraemia caused by BVDV-2 and prevents the birth of persistently infected calves caused by transplacental infection.
Eprinex®

Eprinex®

Depending on formulation, the product is for the treatment of nematodes, lice, mites, ticks, flies and lungworms in cattle and sheep.
Broadline®

Broadline®

Protects cats against the broadest spectrum of internal and external parasites including adult fleas, flea eggs, flea larvae, ticks, heartworms, hookworms, roundworms, and tapeworms.
BTV PUR®

BTV PUR®

Active immunisation of sheep to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).
Keisukes Story

Keisukes Story

Listen to Keisuke, who has heart failure, speak about the impact of his heartbeat moment.
Enterisol® Ileitis

Enterisol® Ileitis

For active immunisation of pigs from the age of three weeks against intestinal lesions caused by Lawsonia intracellularis infection and to reduce growth variability and weight loss associated with the disease.
Avinew

Avinew

In broiler chickens from the age of one day of age: active immunisation against Newcastle disease to reduce mortality and clinical signs associated with the disease.
Championing novel science

Championing novel science

Dr. Vikas Mohan Sharma announces FDA fast-track designation for BI 1358894 as potential treatment for Borderline Personality Disorder.
Światowy Dzień Chorób Rzadkich 2021

Światowy Dzień Chorób Rzadkich 2021

Rzadkie, ale nie zapomniane: dlaczego wsparcie medyczne dla około 30 milionów osób w UE cierpiących na choroby rzadkie1 jest nie do przecenienia
Pierwsza połowa 2024 roku

Pierwsza połowa 2024 roku

Prace badawczo-rozwojowe Boehringer Ingelheim postępują w zakładanym tempie, a spółka osiąga kolejne kamienie milowe